Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.24% Nasdaq Up0.80%

Allergan Inc. (AGN)

-NYSE

104.18 Up 1.03(1.00%) May 10, 4:01PM EDT|After Hours : 104.18 0.00 (0.00%) May 10, 4:24PM EDT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 30, 2012Dec 30, 2011Dec 30, 2010
Total Revenue 5,806,100   5,419,100   4,919,400  
Cost of Revenue775,500  748,700  722,000  
Gross Profit 5,030,600   4,670,400   4,197,400  
Operating Expenses
Research Development989,600  902,800  804,600  
Selling General and Administrative2,268,400  2,246,600  2,017,600  
Non Recurring28,000  28,300  978,600  
Others131,300  127,600  138,000  
Total Operating Expenses3,417,300  3,305,300  3,938,800  
Operating Income or Loss 1,613,300   1,365,100   258,600  
Income from Continuing Operations
Total Other Income/Expenses Net(16,400)6,400  (9,100)
Earnings Before Interest And Taxes1,596,900  1,371,500  249,500  
Interest Expense63,600  71,800  78,700  
Income Before Tax1,533,300  1,299,700  170,800  
Income Tax Expense430,800  361,600  165,900  
Minority Interest(3,700)(3,600)(4,300)
Net Income From Continuing Ops1,098,800  934,500  600  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 1,098,800   934,500   600  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 1,098,800   934,500   600  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.